drugset
drugset / Trial / NCT02680249

Food Effect Study of CTP-656 in Healthy Male Volunteers

NCT02680249 ↗

Phase 1 Completed 15 enrolled Concert Pharmaceuticals
RandomizedCrossoverOpen-labelBasic science

Summary

Three way crossover study to assess the bioavailability of 656 under fed and fasted conditions.

Timeline

Start
2016-02
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject deutivacaftor Unknown 150 mg Oral

Indications

No indication recorded.